Avecho Biotechnology Ord Shs V.AVE

Primary Symbol: AVEFF

Healthcare

Avecho Biotechnology Limited is an Australia-based biopharmaceutical company. The Company develops and commercializes human and animal health products using its drug delivery system called Tocopheryl Phosphate Mixture (TPM). TPM is derived from vitamin E using patented processes. The Company's segments include Production and Human Health. The Production segment manufactures and sells TPM and Vital ET for use in drug delivery and cosmetic formulations. The Human Health portfolio covers delivery of pharmaceutical products through gels, injectables and patches, including conduct of research and development activities. The Company's products pipeline includes Weaner Pig Starter TPM Premix, Poultry TPM Premix, Dairy TPM Premix, Daptomycin, Propofol and Veterinary Applications. The Company is also developing TPM to enhance feed efficiency and the health of livestock. Its TPM products are commercialized under license: Voveran TPM Gel, Instanac TPM Gel, Vital ET, and Ashland TPM.

OTCPK:AVEFF - Post by User

Avecho Biotechnology Ord Shs > Tax implications of holding DASEKE shares within CDN acct's

<< Previous

Bullboard Posts

Next >>

Comment by JohnnyTSXon May 23, 2018 4:37pm

114 Views

Post# 28071730

RE:Tax implications of holding DASEKE shares within CDN acct's

montrus wrote: If I opt for the share consideration, does anyone know if there are tax issues I need to deal with if they are held in my Non-Registered TD or CIBC Canadian investment accounts? Am trying to decide if it's better to sell my AVE shares now OR take the DSKE shares. Any thoughts on this is greatly apprciated.

Mine are in a TFSA but here is something I found online that may be helpful. Appears that it may be deemed a taxible event unless it fits into one of CRA's exceptions, specifically Subsection 85.1(5)

https://taxca.com/blog-2016-14/

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario